Flavonoids - Global Strategic Business Report

Global Flavonoids Market to Reach $2.1 Billion by 2030

The global market for Flavonoids estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Isoflavones, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Anthocyanin segment is readjusted to a revised 3.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $420.4 Million, While China is Forecast to Grow at 6.4% CAGR

The Flavonoids market in the U.S. is estimated at US$420.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$425.9 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$272.4 Million by the year 2030.

Select Competitors (Total 41 Featured) -

• Cayman Chemical Company
• Extrasynthese SAS
• INDOFINE Chemical Company, Inc.
• Quercegen Pharmaceuticals
• Toroma Organics Limited

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year